News + Filings Transactions Holdings
|
Hariri Robert J
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/05/2023 | Celularity Inc | CELU | Purchase | Class A Common Stock | 6.3M | $0.16 | $1M | | 09/29/2023 |
| 10/05/2023 | Celularity Inc | CELU | Purchase | Class A Common Stock | 3.1M | $0.16 | $483.8k | | 09/29/2023 |
| 09/29/2023 | Celularity Inc | CELU | Purchase | Class A Common Stock | 9.1M | $0.17 | $1.5M | | 09/29/2023 |
| 05/12/2023 | Cryoport, Inc. | CYRX | Grant | | 8.1k | $0.00 | $0 | | 05/12/2023 |
| 05/12/2023 | Cryoport, Inc. | CYRX | Grant | Option (Right to Buy Common Stock) | 15.1k | $20.05 | $303.3k | | 05/12/2023 |
| 03/27/2023 | Celularity Inc | CELU | Grant | Class A Common Stock | 2.1M | $0.83 | $1.7M | | 03/27/2023 |
| 03/27/2023 | Celularity Inc | CELU | Grant | Warrants (Right to Buy) | 2.1M | $3.00 | $6.3M | | 03/27/2023 |
| 11/30/2022 | Celularity Inc | CELU | Purchase | Class A Common Stock | 10k | $1.72 | $17.2k | | 11/30/2022 |
| 11/29/2022 | Celularity Inc | CELU | Purchase | Class A Common Stock | 40k | $1.71 | $68.4k | | 11/29/2022 |
| 11/28/2022 | Celularity Inc | CELU | Purchase | Class A Common Stock | 40k | $1.74 | $69.6k | | 11/28/2022 |
| 08/24/2022 | Celularity Inc | CELU | Exercise | Stock Option (Right to Buy) | 119.1k | $2.87 | $341.7k | | 08/24/2022 |
| 08/11/2022 | Cryoport, Inc. | CYRX | Sale | Common Stock | 2k | $43.29 | $86.6k | | 08/11/2022 |
| 04/30/2022 | Cryoport, Inc. | CYRX | Exercise | Restricted Stock Rights | 2.7k | $0.00 | $0 | | 04/29/2022 |
| 04/29/2022 | Cryoport, Inc. | CYRX | Grant | Option (Right to Buy Common Stock) | 14k | $22.56 | $315.4k | | 04/29/2022 |
| 04/29/2022 | Cryoport, Inc. | CYRX | Grant | | 7.2k | $0.00 | $0 | | 04/29/2022 |
| 04/13/2022 | Celularity Inc | CELU | Grant | Class A Common Stock | 131.2k | $0.00 | $0 | | 04/13/2022 |
| 04/13/2022 | Celularity Inc | CELU | Grant | Stock Option (Right to Buy) | 384.8k | $10.16 | $3.9M | | 04/13/2022 |
| 04/05/2022 | BIOVIE INC. | BIVI | Grant | | 122.2k | $5.04 | $616.1k | | 04/05/2022 |
| 09/09/2021 | Celularity Inc | CELU | Grant | Stock Option (Right to Buy) | 2.7M | $10.23 | $27.5M | | 09/09/2021 |
| 07/16/2021 | Celularity Inc | CELU | Grant | Stock Option (Right to Buy) | 1.9M | $10.21 | $19.6M | | 07/16/2021 |
| 07/16/2021 | Celularity Inc | CELU | Grant | Stock Option (Right to Buy) | 384.3k | $3.70 | $1.4M | | 07/16/2021 |
| 07/16/2021 | Celularity Inc | CELU | Grant | Stock Option (Right to Buy) | 174.7k | $3.88 | $677.8k | | 07/16/2021 |
| 07/16/2021 | Celularity Inc | CELU | Grant | Stock Option (Right to Buy) | 349.4k | $2.87 | $1M | | 07/16/2021 |
| 07/16/2021 | Celularity Inc | CELU | Other (acquisition) | Class A Common Stock | 7.7M | $0.00 | $0 | | 07/16/2021 |
| 04/30/2021 | Cryoport, Inc. | CYRX | Grant | Option to purchase common stock | 5.4k | $56.57 | $306.4k | | 04/30/2021 |
| 04/30/2021 | Cryoport, Inc. | CYRX | Grant | Restricted Stock Rights | 2.7k | $0.00 | $0 | | 04/30/2021 |
| 07/20/2020 | Cryoport, Inc. | CYRX | Exercise (in-the-money or at-the-money) | Warrants to purchase common stock | 15.3k | $3.57 | $54.6k | | 07/20/2020 |
| 05/01/2020 | Cryoport, Inc. | CYRX | Grant | Options to purchase common stock | 35k | $18.02 | $630.7k | | 05/01/2020 |
| 03/31/2020 | MedAvail Holdings, Inc. | MDVL | Grant | Common Stock | 3.3k | $0.00 | $0 | | 03/31/2020 |
| 05/02/2019 | Cryoport, Inc. | CYRX | Grant | Options to purchase common stock | 35k | $14.35 | $502.2k | | 05/02/2019 |
| 02/06/2019 | MedAvail Holdings, Inc. | MDVL | Grant | Common Stock | 11k | $0.00 | $0 | | 02/06/2019 |
| 05/17/2018 | Cryoport, Inc. | CYRX | Grant | Options to purchase common stock | 35k | $9.29 | $325.2k | | 06/23/2017 |
| 01/03/2018 | MedAvail Holdings, Inc. | MDVL | Grant | Common Stock | 7.4k | $0.00 | $0 | | 01/03/2018 |
| 06/23/2017 | Cryoport, Inc. | CYRX | Grant | Options to purchase common stock | 35k | $4.80 | $168k | | 06/23/2017 |
| 12/17/2015 | MedAvail Holdings, Inc. | MDVL | Purchase | Common Stock | 1000 | $2.73 | $2.7k | | 12/17/2015 |
|
|